Table 2.
Clinical characteristics of grouped serotypes
|
Serotype group |
All patients |
Fatal outcome |
Any risk factor |
Pneumonia |
Meningitis |
<2 years |
|||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| (all = 233) | (all = 233) | (all = 229) | (all = 229) | (all = 244) | |||||||
| |
No |
No(%) |
P-value |
No(%) |
P-value |
No(%) |
P-value |
No(%) |
P-value |
No(%) |
P-value |
| Invasive |
59 |
8 (14%) |
ns |
25 (46.3%) |
0.002 |
40 (75.5%) |
<0.001 |
8 (15%) |
ns (0.07) |
5 (9%) |
ns (0.07) |
| Pediatric |
91 |
20 (23%) |
ns |
53 (60.2%) |
ns |
30 (35.3%) |
0.039 |
29 (34%) |
0.03 |
26 (29%) |
<0.001 |
| PCV10 |
128 |
23 (19%) |
ns |
68 (55.7%) |
0.003 |
65 (54.6%) |
0.001 |
28 (24%) |
ns |
27 (21%) |
ns |
| PCV13 |
157 |
32 (21%) |
ns |
87 (58.0%) |
0.004 |
76 (51.7%) |
0.004 |
31 (21%) |
ns (0.06) |
29 (19%) |
ns |
| All serotypes | 244 | 49 (21%) | 151 (64.8%) | 102 (44.5%) | 58 (25%) | 41 (17%) | |||||
Clinical characteristics related to pneumococcal serotypes clustered into “invasive”, “pediatric”, PCV10 and PCV13 serotypes, with each group compared with all other serotypes. P-values calculated with Fisher’s exact test (two-sided).